Share on LinkedInShare on LinkedIn

ARTICLE · 25 JANUARY 2007

Share Incentive Trends For Second Half 2006 Biotech Floats

We have reviewed the London floats of biotech companies in the second half of 2006. Enclosed is a note on a number of points of interest, showing that option schemes continue to be important to the sector.

United KingdomFinance and Banking
Nicholas Stretch
Nicholas Stretch
Michael Draper
Michael Draper
Sarah Hanson
Sarah Hanson
Niall McAlister
Niall McAlister

We have reviewed the London floats of biotech companies in the second half of 2006. Enclosed is a note on a number of points of interest, showing that option schemes continue to be important to the sector.

To view the article in full, please see below:


Full Article

We have reviewed the London floats of biotech companies in the second half of 2006. Below is a note on a number of points of interest, showing that option schemes continue to be important to the sector.

The following outlines the main points of interest relating to biotech floats in London in the second half of 2006:

  • 7 biotech companies floated on the main London list and AIM between 1 May 2006 and 31 December 2006. Many were structured as reverse take overs ie a biotech company moved into an existing quoted company.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from